Cargando…

A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout

BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Jane C., Liddle, Jennifer, Mallen, Christian D., Roddy, Edward, Hider, Samantha, Prinjha, Suman, Ziebland, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895958/
https://www.ncbi.nlm.nih.gov/pubmed/27267878
http://dx.doi.org/10.1186/s12891-016-1117-5
_version_ 1782435956707557376
author Richardson, Jane C.
Liddle, Jennifer
Mallen, Christian D.
Roddy, Edward
Hider, Samantha
Prinjha, Suman
Ziebland, Sue
author_facet Richardson, Jane C.
Liddle, Jennifer
Mallen, Christian D.
Roddy, Edward
Hider, Samantha
Prinjha, Suman
Ziebland, Sue
author_sort Richardson, Jane C.
collection PubMed
description BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient experience and understanding of ULT treatment for gout. METHODS: A qualitative study was conducted throughout the United Kingdom. Narrative and semi-structured video-recorded interviews and thematic analysis were used. RESULTS: Participants talked about their views and experiences of treatment, and the factors that affected their use of ULT. The analysis revealed five main themes: 1) knowledge and understanding of gout and its treatment; 2) resistance to taking medication; 3) uncertainty about when to start ULT; 4) experiences of using ULT; and 5) desire for information and monitoring. CONCLUSION: Patients’ understanding and experiences of gout and ULT are complex and it is important for clinicians to be aware of these when working with patients. It is also important for clinicians to know that patients’ perceptions and behaviour are not fixed, but can change over time, with changes to their condition, with dialogue and increased understanding. Patients want this interaction with their clinicians, through “a joint effort over a period of time”.
format Online
Article
Text
id pubmed-4895958
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48959582016-06-08 A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout Richardson, Jane C. Liddle, Jennifer Mallen, Christian D. Roddy, Edward Hider, Samantha Prinjha, Suman Ziebland, Sue BMC Musculoskelet Disord Research Article BACKGROUND: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient experience and understanding of ULT treatment for gout. METHODS: A qualitative study was conducted throughout the United Kingdom. Narrative and semi-structured video-recorded interviews and thematic analysis were used. RESULTS: Participants talked about their views and experiences of treatment, and the factors that affected their use of ULT. The analysis revealed five main themes: 1) knowledge and understanding of gout and its treatment; 2) resistance to taking medication; 3) uncertainty about when to start ULT; 4) experiences of using ULT; and 5) desire for information and monitoring. CONCLUSION: Patients’ understanding and experiences of gout and ULT are complex and it is important for clinicians to be aware of these when working with patients. It is also important for clinicians to know that patients’ perceptions and behaviour are not fixed, but can change over time, with changes to their condition, with dialogue and increased understanding. Patients want this interaction with their clinicians, through “a joint effort over a period of time”. BioMed Central 2016-06-06 /pmc/articles/PMC4895958/ /pubmed/27267878 http://dx.doi.org/10.1186/s12891-016-1117-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Richardson, Jane C.
Liddle, Jennifer
Mallen, Christian D.
Roddy, Edward
Hider, Samantha
Prinjha, Suman
Ziebland, Sue
A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title_full A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title_fullStr A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title_full_unstemmed A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title_short A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
title_sort joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895958/
https://www.ncbi.nlm.nih.gov/pubmed/27267878
http://dx.doi.org/10.1186/s12891-016-1117-5
work_keys_str_mv AT richardsonjanec ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT liddlejennifer ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT mallenchristiand ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT roddyedward ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT hidersamantha ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT prinjhasuman ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT zieblandsue ajointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT richardsonjanec jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT liddlejennifer jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT mallenchristiand jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT roddyedward jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT hidersamantha jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT prinjhasuman jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout
AT zieblandsue jointeffortoveraperiodoftimefactorsaffectinguseofurateloweringtherapyforlongtermtreatmentofgout